有効成分(API)のグローバル及び中国市場 2027年

調査会社QYResearch社が発行したリサーチレポート(データ管理コード:QY21CN0335)
◆英語タイトル:Global and China Active Pharmaceutical Ingredients (API) Market Insights, Forecast to 2027
◆発行会社/調査会社:QYResearch
◆商品コード:QY21CN0335
◆発行日:2021年7月6日
◆調査対象地域:グローバル、中国
◆産業分野:化学&材料
◆ページ数:162
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール(24時間以内)
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥444,600見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥666,900見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥889,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[有効成分(API)のグローバル及び中国市場 2027年]についてメールでお問い合わせはこちら
当調査レポートではグローバルにおける有効成分(API)の市場規模(2016年-2027年)と動向についてまとめました。中国市場については主要プレイヤーの市場シェア、有効成分(API)の種類別市場規模(合成API、バイオテクノロジーAPI)、用途別市場規模(CNS、循環器、泌尿生殖器/ホルモン剤、呼吸器、リウマチ、糖尿病、腫瘍学、その他)も掲載しています。他に、北米・アメリカ市場、ヨーロッパ市場、アジア太平洋・日本市場、中南米市場、中東・アフリカ市場の市場規模、グローバル市場機会・課題・リスク要因、バリューチェーン・販売チャネル、主要プレイヤーの情報なども掲載しています。
・調査の概要
・調査のサマリー
・世界の有効成分(API)市場動向
・グローバル主要プレイヤーの競争状況・市場シェア
・世界における有効成分(API)の種類別市場規模(2016年-2027年):合成API、バイオテクノロジーAPI
・世界における有効成分(API)の用途別市場規模(2016年-2027年):CNS、循環器、泌尿生殖器/ホルモン剤、呼吸器、リウマチ、糖尿病、腫瘍学、その他
・有効成分(API)の中国市場分析
- 有効成分(API)の中国市場規模(2016年-2027年)
- 中国における有効成分(API)の主要プレイヤー別市場シェア
- 中国における有効成分(API)の種類別市場規模:合成API、バイオテクノロジーAPI
- 中国における有効成分(API)の用途別市場規模:CNS、循環器、泌尿生殖器/ホルモン剤、呼吸器、リウマチ、糖尿病、腫瘍学、その他
・有効成分(API)の北米市場(2016年-2027年)
・有効成分(API)のヨーロッパ市場(2016年-2027年)
・有効成分(API)のアジア太平洋市場(2016年-2027年)
・有効成分(API)の中南米市場(2016年-2027年)
・有効成分(API)の中東・アフリカ市場(2016年-2027年)
・主要プレイヤーの情報:Teva、Mylan、DSM、Aurobindo Pharma、Aspen、Novartis、BASF、Pfizer、Huahai Pharmaceutical、Hisun Pharmaceutical、Sun Pharmaceutical Industries、Zhejiang Medicine、Dr. Reddy’s Laboratories、Zhejiang NHU、Bayer、NCPC、AbbVie、Shandong Xinhua Pharmaceutical、Northeast Pharm、Harbin Pharmaceutical、LKPC
・市場機会・課題・リスク要因分析
・バリューチェーン・販売チャネル分析
・...
*** レポート概要(サマリー)***

An active ingredient (AI) is the ingredient in a pharmaceutical drug that is biologically active. The similar terms active pharmaceutical ingredient (API) and bulk active are also used in medicine, and the term active substance may be used for natural products. Some medication products may contain more than one active ingredient. The traditional word for the API is pharmacon or pharmakon which originally denoted a magical substance or drug.
India is the largest region of Active Pharmaceutical Ingredients (API), with a market share about 30%. Teva Active Pharmaceutical Industries Limited, DSM, Novartis, Roche and Johnson & Johnson are the top 5 manufacturers of industry.

Market Analysis and Insights: Global and China Active Pharmaceutical Ingredients (API) Market
This report focuses on global and China Active Pharmaceutical Ingredients (API) market.
In 2020, the global Active Pharmaceutical Ingredients (API) market size was US$ 67700 million and it is expected to reach US$ 105780 million by the end of 2027, with a CAGR of 6.6% during 2021-2027. In China the Active Pharmaceutical Ingredients (API) market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Active Pharmaceutical Ingredients (API) Scope and Market Size
Active Pharmaceutical Ingredients (API) market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Active Pharmaceutical Ingredients (API) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For China market, this report focuses on the Active Pharmaceutical Ingredients (API) market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.

Segment by Type
Synthetic APIs
Biotech APIs

Segment by Application
CNS
Cardiovascular
Genitourinary/Hormonal Drugs
Respiratory
Rheumatology
Diabetes
Oncology
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

By Company
Teva
Mylan
DSM
Aurobindo Pharma
Aspen
Novartis
BASF
Pfizer
Huahai Pharmaceutical
Hisun Pharmaceutical
Sun Pharmaceutical Industries
Zhejiang Medicine
Dr. Reddy’s Laboratories
Zhejiang NHU
Bayer
NCPC
AbbVie
Shandong Xinhua Pharmaceutical
Northeast Pharm
Harbin Pharmaceutical
LKPC

*** レポート目次(コンテンツ)***

1 Study Coverage
1.1 Active Pharmaceutical Ingredients (API) Product Introduction
1.2 Market by Type
1.2.1 Global Active Pharmaceutical Ingredients (API) Market Size Growth Rate by Type
1.2.2 Synthetic APIs
1.2.3 Biotech APIs
1.3 Market by Application
1.3.1 Global Active Pharmaceutical Ingredients (API) Market Size Growth Rate by Application
1.3.2 CNS
1.3.3 Cardiovascular
1.3.4 Genitourinary/Hormonal Drugs
1.3.5 Respiratory
1.3.6 Rheumatology
1.3.7 Diabetes
1.3.8 Oncology
1.3.9 Others
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Active Pharmaceutical Ingredients (API) Market Size, Estimates and Forecasts
2.1.1 Global Active Pharmaceutical Ingredients (API) Revenue 2016-2027
2.1.2 Global Active Pharmaceutical Ingredients (API) Sales 2016-2027
2.2 Global Active Pharmaceutical Ingredients (API), Market Size by Region: 2016 VS 2021 VS 2027
2.3 Active Pharmaceutical Ingredients (API) Historical Market Size by Region (2016-2021)
2.3.1 Global Active Pharmaceutical Ingredients (API) Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Active Pharmaceutical Ingredients (API) Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Active Pharmaceutical Ingredients (API) Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Active Pharmaceutical Ingredients (API) Sales Forecast by Region (2022-2027)
2.4.2 Global Active Pharmaceutical Ingredients (API) Revenue Forecast by Region (2022-2027)

3 Global Active Pharmaceutical Ingredients (API) Competitor Landscape by Players
3.1 Global Top Active Pharmaceutical Ingredients (API) Manufacturers by Sales
3.1.1 Global Active Pharmaceutical Ingredients (API) Sales by Manufacturer (2016-2021)
3.1.2 Global Active Pharmaceutical Ingredients (API) Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Active Pharmaceutical Ingredients (API) Manufacturers by Revenue
3.2.1 Key Active Pharmaceutical Ingredients (API) Manufacturers Covered: Ranking by Revenue
3.2.2 Global Active Pharmaceutical Ingredients (API) Revenue by Manufacturers (2016-2021)
3.2.3 Global Active Pharmaceutical Ingredients (API) Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Active Pharmaceutical Ingredients (API) Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Active Pharmaceutical Ingredients (API) Revenue in 2020
3.2.6 Global Active Pharmaceutical Ingredients (API) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Active Pharmaceutical Ingredients (API) Price by Manufacturers
3.4 Global Active Pharmaceutical Ingredients (API) Manufacturing Base Distribution, Product Types
3.4.1 Active Pharmaceutical Ingredients (API) Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Active Pharmaceutical Ingredients (API) Product Type
3.4.3 Date of International Manufacturers Enter into Active Pharmaceutical Ingredients (API) Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2016-2027)
4.1 Global Active Pharmaceutical Ingredients (API) Market Size by Type (2016-2021)
4.1.1 Global Active Pharmaceutical Ingredients (API) Sales by Type (2016-2021)
4.1.2 Global Active Pharmaceutical Ingredients (API) Revenue by Type (2016-2021)
4.1.3 Active Pharmaceutical Ingredients (API) Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Active Pharmaceutical Ingredients (API) Market Size Forecast by Type (2022-2027)
4.2.1 Global Active Pharmaceutical Ingredients (API) Sales Forecast by Type (2022-2027)
4.2.2 Global Active Pharmaceutical Ingredients (API) Revenue Forecast by Type (2022-2027)
4.2.3 Active Pharmaceutical Ingredients (API) Average Selling Price (ASP) Forecast by Type (2022-2027)

5 Breakdown Data by Application (2016-2027)
5.1 Global Active Pharmaceutical Ingredients (API) Market Size by Application (2016-2021)
5.1.1 Global Active Pharmaceutical Ingredients (API) Sales by Application (2016-2021)
5.1.2 Global Active Pharmaceutical Ingredients (API) Revenue by Application (2016-2021)
5.1.3 Active Pharmaceutical Ingredients (API) Price by Application (2016-2021)
5.2 Active Pharmaceutical Ingredients (API) Market Size Forecast by Application (2022-2027)
5.2.1 Global Active Pharmaceutical Ingredients (API) Sales Forecast by Application (2022-2027)
5.2.2 Global Active Pharmaceutical Ingredients (API) Revenue Forecast by Application (2022-2027)
5.2.3 Global Active Pharmaceutical Ingredients (API) Price Forecast by Application (2022-2027)

6 China by Players, Type and Application
6.1 China Active Pharmaceutical Ingredients (API) Market Size YoY Growth 2016-2027
6.1.1 China Active Pharmaceutical Ingredients (API) Sales YoY Growth 2016-2027
6.1.2 China Active Pharmaceutical Ingredients (API) Revenue YoY Growth 2016-2027
6.1.3 China Active Pharmaceutical Ingredients (API) Market Share in Global Market 2016-2027
6.2 China Active Pharmaceutical Ingredients (API) Market Size by Players (International and Local Players)
6.2.1 China Top Active Pharmaceutical Ingredients (API) Players by Sales (2016-2021)
6.2.2 China Top Active Pharmaceutical Ingredients (API) Players by Revenue (2016-2021)
6.3 China Active Pharmaceutical Ingredients (API) Historic Market Review by Type (2016-2021)
6.3.1 China Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2016-2021)
6.3.2 China Active Pharmaceutical Ingredients (API) Revenue Market Share by Type (2016-2021)
6.3.3 China Active Pharmaceutical Ingredients (API) Price by Type (2016-2021)
6.4 China Active Pharmaceutical Ingredients (API) Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Active Pharmaceutical Ingredients (API) Sales Forecast by Type (2022-2027)
6.4.2 China Active Pharmaceutical Ingredients (API) Revenue Forecast by Type (2022-2027)
6.4.3 China Active Pharmaceutical Ingredients (API) Price Forecast by Type (2022-2027)
6.5 China Active Pharmaceutical Ingredients (API) Historic Market Review by Application (2016-2021)
6.5.1 China Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2016-2021)
6.5.2 China Active Pharmaceutical Ingredients (API) Revenue Market Share by Application (2016-2021)
6.5.3 China Active Pharmaceutical Ingredients (API) Price by Application (2016-2021)
6.6 China Active Pharmaceutical Ingredients (API) Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Active Pharmaceutical Ingredients (API) Sales Forecast by Application (2022-2027)
6.6.2 China Active Pharmaceutical Ingredients (API) Revenue Forecast by Application (2022-2027)
6.6.3 China Active Pharmaceutical Ingredients (API) Price Forecast by Application (2022-2027)

7 North America
7.1 North America Active Pharmaceutical Ingredients (API) Market Size YoY Growth 2016-2027
7.2 North America Active Pharmaceutical Ingredients (API) Market Facts & Figures by Country
7.2.1 North America Active Pharmaceutical Ingredients (API) Sales by Country (2016-2021)
7.2.2 North America Active Pharmaceutical Ingredients (API) Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada

8 Asia Pacific
8.1 Asia Pacific Active Pharmaceutical Ingredients (API) Market Size YoY Growth 2016-2027
8.2 Asia Pacific Active Pharmaceutical Ingredients (API) Market Facts & Figures by Region
8.2.1 Asia Pacific Active Pharmaceutical Ingredients (API) Sales by Region (2016-2021)
8.2.2 Asia Pacific Active Pharmaceutical Ingredients (API) Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam

9 Europe
9.1 Europe Active Pharmaceutical Ingredients (API) Market Size YoY Growth 2016-2027
9.2 Europe Active Pharmaceutical Ingredients (API) Market Facts & Figures by Country
9.2.1 Europe Active Pharmaceutical Ingredients (API) Sales by Country (2016-2021)
9.2.2 Europe Active Pharmaceutical Ingredients (API) Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy

10 Latin America
10.1 Latin America Active Pharmaceutical Ingredients (API) Market Size YoY Growth 2016-2027
10.2 Latin America Active Pharmaceutical Ingredients (API) Market Facts & Figures by Country
10.2.1 Latin America Active Pharmaceutical Ingredients (API) Sales by Country (2016-2021)
10.2.2 Latin America Active Pharmaceutical Ingredients (API) Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Active Pharmaceutical Ingredients (API) Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Active Pharmaceutical Ingredients (API) Market Facts & Figures by Country
11.2.1 Middle East and Africa Active Pharmaceutical Ingredients (API) Sales by Country (2016-2021)
11.2.2 Middle East and Africa Active Pharmaceutical Ingredients (API) Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E

12 Company Profiles
12.1 Teva
12.1.1 Teva Corporation Information
12.1.2 Teva Description and Business Overview
12.1.3 Teva Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Teva Active Pharmaceutical Ingredients (API) Products Offered
12.1.5 Teva Recent Development
12.2 Mylan
12.2.1 Mylan Corporation Information
12.2.2 Mylan Description and Business Overview
12.2.3 Mylan Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Mylan Active Pharmaceutical Ingredients (API) Products Offered
12.2.5 Mylan Recent Development
12.3 DSM
12.3.1 DSM Corporation Information
12.3.2 DSM Description and Business Overview
12.3.3 DSM Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2016-2021)
12.3.4 DSM Active Pharmaceutical Ingredients (API) Products Offered
12.3.5 DSM Recent Development
12.4 Aurobindo Pharma
12.4.1 Aurobindo Pharma Corporation Information
12.4.2 Aurobindo Pharma Description and Business Overview
12.4.3 Aurobindo Pharma Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Aurobindo Pharma Active Pharmaceutical Ingredients (API) Products Offered
12.4.5 Aurobindo Pharma Recent Development
12.5 Aspen
12.5.1 Aspen Corporation Information
12.5.2 Aspen Description and Business Overview
12.5.3 Aspen Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Aspen Active Pharmaceutical Ingredients (API) Products Offered
12.5.5 Aspen Recent Development
12.6 Novartis
12.6.1 Novartis Corporation Information
12.6.2 Novartis Description and Business Overview
12.6.3 Novartis Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Novartis Active Pharmaceutical Ingredients (API) Products Offered
12.6.5 Novartis Recent Development
12.7 BASF
12.7.1 BASF Corporation Information
12.7.2 BASF Description and Business Overview
12.7.3 BASF Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2016-2021)
12.7.4 BASF Active Pharmaceutical Ingredients (API) Products Offered
12.7.5 BASF Recent Development
12.8 Pfizer
12.8.1 Pfizer Corporation Information
12.8.2 Pfizer Description and Business Overview
12.8.3 Pfizer Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Pfizer Active Pharmaceutical Ingredients (API) Products Offered
12.8.5 Pfizer Recent Development
12.9 Huahai Pharmaceutical
12.9.1 Huahai Pharmaceutical Corporation Information
12.9.2 Huahai Pharmaceutical Description and Business Overview
12.9.3 Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Products Offered
12.9.5 Huahai Pharmaceutical Recent Development
12.10 Hisun Pharmaceutical
12.10.1 Hisun Pharmaceutical Corporation Information
12.10.2 Hisun Pharmaceutical Description and Business Overview
12.10.3 Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Products Offered
12.10.5 Hisun Pharmaceutical Recent Development
12.11 Teva
12.11.1 Teva Corporation Information
12.11.2 Teva Description and Business Overview
12.11.3 Teva Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Teva Active Pharmaceutical Ingredients (API) Products Offered
12.11.5 Teva Recent Development
12.12 Zhejiang Medicine
12.12.1 Zhejiang Medicine Corporation Information
12.12.2 Zhejiang Medicine Description and Business Overview
12.12.3 Zhejiang Medicine Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Zhejiang Medicine Products Offered
12.12.5 Zhejiang Medicine Recent Development
12.13 Dr. Reddy’s Laboratories
12.13.1 Dr. Reddy’s Laboratories Corporation Information
12.13.2 Dr. Reddy’s Laboratories Description and Business Overview
12.13.3 Dr. Reddy’s Laboratories Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Dr. Reddy’s Laboratories Products Offered
12.13.5 Dr. Reddy’s Laboratories Recent Development
12.14 Zhejiang NHU
12.14.1 Zhejiang NHU Corporation Information
12.14.2 Zhejiang NHU Description and Business Overview
12.14.3 Zhejiang NHU Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Zhejiang NHU Products Offered
12.14.5 Zhejiang NHU Recent Development
12.15 Bayer
12.15.1 Bayer Corporation Information
12.15.2 Bayer Description and Business Overview
12.15.3 Bayer Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Bayer Products Offered
12.15.5 Bayer Recent Development
12.16 NCPC
12.16.1 NCPC Corporation Information
12.16.2 NCPC Description and Business Overview
12.16.3 NCPC Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2016-2021)
12.16.4 NCPC Products Offered
12.16.5 NCPC Recent Development
12.17 AbbVie
12.17.1 AbbVie Corporation Information
12.17.2 AbbVie Description and Business Overview
12.17.3 AbbVie Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2016-2021)
12.17.4 AbbVie Products Offered
12.17.5 AbbVie Recent Development
12.18 Shandong Xinhua Pharmaceutical
12.18.1 Shandong Xinhua Pharmaceutical Corporation Information
12.18.2 Shandong Xinhua Pharmaceutical Description and Business Overview
12.18.3 Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2016-2021)
12.18.4 Shandong Xinhua Pharmaceutical Products Offered
12.18.5 Shandong Xinhua Pharmaceutical Recent Development
12.19 Northeast Pharm
12.19.1 Northeast Pharm Corporation Information
12.19.2 Northeast Pharm Description and Business Overview
12.19.3 Northeast Pharm Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2016-2021)
12.19.4 Northeast Pharm Products Offered
12.19.5 Northeast Pharm Recent Development
12.20 Harbin Pharmaceutical
12.20.1 Harbin Pharmaceutical Corporation Information
12.20.2 Harbin Pharmaceutical Description and Business Overview
12.20.3 Harbin Pharmaceutical Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2016-2021)
12.20.4 Harbin Pharmaceutical Products Offered
12.20.5 Harbin Pharmaceutical Recent Development
12.21 LKPC
12.21.1 LKPC Corporation Information
12.21.2 LKPC Description and Business Overview
12.21.3 LKPC Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2016-2021)
12.21.4 LKPC Products Offered
12.21.5 LKPC Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Active Pharmaceutical Ingredients (API) Industry Trends
13.2 Active Pharmaceutical Ingredients (API) Market Drivers
13.3 Active Pharmaceutical Ingredients (API) Market Challenges
13.4 Active Pharmaceutical Ingredients (API) Market Restraints

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Active Pharmaceutical Ingredients (API) Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Global Active Pharmaceutical Ingredients (API) Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Synthetic APIs
Table 3. Major Manufacturers of Biotech APIs
Table 4. Global Active Pharmaceutical Ingredients (API) Market Size Growth Rate by Application (2021-2027) & (Tons)
Table 5. Global Active Pharmaceutical Ingredients (API) Market Size by Region (Tons) & (US$ Million), 2016 VS 2021 VS 2027
Table 6. Global Active Pharmaceutical Ingredients (API) Sales by Regions (2016-2021) & (Tons)
Table 7. Global Active Pharmaceutical Ingredients (API) Sales Market Share by Regions (2016-2021)
Table 8. Global Active Pharmaceutical Ingredients (API) Revenue by Regions (2016-2021) & (US$ Million)
Table 9. Global Active Pharmaceutical Ingredients (API) Sales Forecast by Region (2022-2027) & (Tons)
Table 10. Global Active Pharmaceutical Ingredients (API) Sales Market Share Forecast by Region (2022-2027)
Table 11. Global Active Pharmaceutical Ingredients (API) Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 12. Global Active Pharmaceutical Ingredients (API) Revenue Market Share Forecast by Region (2022-2027)
Table 13. Global Active Pharmaceutical Ingredients (API) Sales by Manufacturers (2016-2021) (Tons)
Table 14. Global Active Pharmaceutical Ingredients (API) Sales Share by Manufacturers (2016-2021)
Table 15. Ranking of Global Top Active Pharmaceutical Ingredients (API) Manufacturers by Revenue (US$ Million) in 2020
Table 16. Active Pharmaceutical Ingredients (API) Revenue by Manufacturers (2016-2021) (US$ Million)
Table 17. Active Pharmaceutical Ingredients (API) Revenue Share by Manufacturers (2016-2021)
Table 18. Global Active Pharmaceutical Ingredients (API) Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 19. Global Active Pharmaceutical Ingredients (API) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Active Pharmaceutical Ingredients (API) as of 2020)
Table 20. Key Manufacturers Active Pharmaceutical Ingredients (API) Price (2016-2021) (USD/Ton)
Table 21. Active Pharmaceutical Ingredients (API) Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Active Pharmaceutical Ingredients (API) Product Type
Table 23. Date of International Manufacturers Enter into Active Pharmaceutical Ingredients (API) Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Active Pharmaceutical Ingredients (API) Sales by Type (2016-2021) (Tons)
Table 26. Global Active Pharmaceutical Ingredients (API) Sales Share by Type (2016-2021)
Table 27. Global Active Pharmaceutical Ingredients (API) Revenue by Type (2016-2021) (US$ Million)
Table 28. Global Active Pharmaceutical Ingredients (API) Revenue Share by Type (2016-2021)
Table 29. Active Pharmaceutical Ingredients (API) Average Selling Price (ASP) by Type (2016-2021) & (USD/Ton)
Table 30. Global Active Pharmaceutical Ingredients (API) Sales Forecast by Type (2022-2027) & (Tons)
Table 31. Global Active Pharmaceutical Ingredients (API) Sales Market Share Forecast by Type (2022-2027)
Table 32. Global Active Pharmaceutical Ingredients (API) Revenue Forecast V (2022-2027) & (US$ Million)
Table 33. Global Active Pharmaceutical Ingredients (API) Revenue Market Share Forecast by Type (2022-2027)
Table 34. Global Active Pharmaceutical Ingredients (API) Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Ton)
Table 35. Global Active Pharmaceutical Ingredients (API) Sales by Application (2016-2021) (Tons)
Table 36. Global Active Pharmaceutical Ingredients (API) Sales Share by Application (2016-2021)
Table 37. Global Active Pharmaceutical Ingredients (API) Revenue by Application (2016-2021) (US$ Million)
Table 38. Global Active Pharmaceutical Ingredients (API) Revenue Share by Application (2016-2021)
Table 39. Active Pharmaceutical Ingredients (API) Average Selling Price (ASP) by Application (2016-2021) & (USD/Ton)
Table 40. Global Active Pharmaceutical Ingredients (API) Sales Forecast by Application (2022-2027) & (Tons)
Table 41. Global Active Pharmaceutical Ingredients (API) Sales Market Share Forecast by Application (2022-2027)
Table 42. Global Active Pharmaceutical Ingredients (API) Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 43. Global Active Pharmaceutical Ingredients (API) Revenue Market Share Forecast by Application (2022-2027)
Table 44. Global Active Pharmaceutical Ingredients (API) Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Ton)
Table 45. China Active Pharmaceutical Ingredients (API) Sales (Tons) of Key Companies (2016-2021)
Table 46. China Active Pharmaceutical Ingredients (API) Sales Share by Company (2016-2021)
Table 47. China Active Pharmaceutical Ingredients (API) Revenue (US$ Million) by Company (2016-2021)
Table 48. China Active Pharmaceutical Ingredients (API) Revenue Share by Company (2016-2021)
Table 49. China Active Pharmaceutical Ingredients (API) Sales (Tons) by Type (2016-2021)
Table 50. China Active Pharmaceutical Ingredients (API) Sales Share by Type (2016-2021)
Table 51. China Active Pharmaceutical Ingredients (API) Revenue (US$ Million) Market Share by Type (2016-2021)
Table 52. China Active Pharmaceutical Ingredients (API) Price (USD/Ton) by Type (2016-2021)
Table 53. China Active Pharmaceutical Ingredients (API) Sales (Tons) by Type (2022-2027)
Table 54. China Active Pharmaceutical Ingredients (API) Sales Share by Type (2022-2027)
Table 55. China Active Pharmaceutical Ingredients (API) Revenue (US$ Million) Market Share by Type (2022-2027)
Table 56. China Active Pharmaceutical Ingredients (API) Revenue Share by Type (2022-2027)
Table 57. China Active Pharmaceutical Ingredients (API) Price (USD/Ton) by Type (2022-2027)
Table 58. China Active Pharmaceutical Ingredients (API) Sales (Tons) by Application (2016-2021)
Table 59. China Active Pharmaceutical Ingredients (API) Sales Share by Application (2016-2021)
Table 60. China Active Pharmaceutical Ingredients (API) Revenue (US$ Million) Market Share by Application (2016-2021)
Table 61. China Active Pharmaceutical Ingredients (API) Price (USD/Ton) by Application (2016-2021)
Table 62. China Active Pharmaceutical Ingredients (API) Sales (Tons) by Application (2022-2027)
Table 63. China Active Pharmaceutical Ingredients (API) Sales Share by Application (2022-2027)
Table 64. China Active Pharmaceutical Ingredients (API) Revenue (US$ Million) Market Share by Application (2022-2027)
Table 65. China Active Pharmaceutical Ingredients (API) Revenue Share by Application (2022-2027)
Table 66. China Active Pharmaceutical Ingredients (API) Price (USD/Ton) by Application (2022-2027)
Table 67. North America Active Pharmaceutical Ingredients (API) Sales by Country (2016-2021) & (Tons)
Table 68. North America Active Pharmaceutical Ingredients (API) Sales Market Share by Country (2016-2021)
Table 69. North America Active Pharmaceutical Ingredients (API) Revenue by Country (2016-2021) & (US$ Million)
Table 70. North America Active Pharmaceutical Ingredients (API) Revenue Market Share by Country (2016-2021)
Table 71. Asia Pacific Active Pharmaceutical Ingredients (API) Sales by Region (2016-2021) & (Tons)
Table 72. Asia Pacific Active Pharmaceutical Ingredients (API) Sales Market Share by Region (2016-2021)
Table 73. Asia Pacific Active Pharmaceutical Ingredients (API) Revenue by Region (2016-2021) & (US$ Million)
Table 74. Asia Pacific Active Pharmaceutical Ingredients (API) Revenue Market Share by Region (2016-2021)
Table 75. Europe Active Pharmaceutical Ingredients (API) Sales by Country (2016-2021) & (Tons)
Table 76. Europe Active Pharmaceutical Ingredients (API) Sales Market Share by Country (2016-2021)
Table 77. Europe Active Pharmaceutical Ingredients (API) Revenue by Country (2016-2021) & (US$ Million)
Table 78. Europe Active Pharmaceutical Ingredients (API) Revenue Market Share by Country (2016-2021)
Table 79. Latin America Active Pharmaceutical Ingredients (API) Sales by Country (2016-2021) & (Tons)
Table 80. Latin America Active Pharmaceutical Ingredients (API) Sales Market Share by Country (2016-2021)
Table 81. Latin Americaa Active Pharmaceutical Ingredients (API) Revenue by Country (2016-2021) & (US$ Million)
Table 82. Latin America Active Pharmaceutical Ingredients (API) Revenue Market Share by Country (2016-2021)
Table 83. Middle East and Africa Active Pharmaceutical Ingredients (API) Sales by Country (2016-2021) & (Tons)
Table 84. Middle East and Africa Active Pharmaceutical Ingredients (API) Sales Market Share by Country (2016-2021)
Table 85. Middle East and Africa Active Pharmaceutical Ingredients (API) Revenue by Country (2016-2021) & (US$ Million)
Table 86. Middle East and Africa Active Pharmaceutical Ingredients (API) Revenue Market Share by Country (2016-2021)
Table 87. Teva Corporation Information
Table 88. Teva Description and Business Overview
Table 89. Teva Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2016-2021)
Table 90. Teva Active Pharmaceutical Ingredients (API) Product
Table 91. Teva Recent Development
Table 92. Mylan Corporation Information
Table 93. Mylan Description and Business Overview
Table 94. Mylan Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2016-2021)
Table 95. Mylan Product
Table 96. Mylan Recent Development
Table 97. DSM Corporation Information
Table 98. DSM Description and Business Overview
Table 99. DSM Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2016-2021)
Table 100. DSM Product
Table 101. DSM Recent Development
Table 102. Aurobindo Pharma Corporation Information
Table 103. Aurobindo Pharma Description and Business Overview
Table 104. Aurobindo Pharma Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2016-2021)
Table 105. Aurobindo Pharma Product
Table 106. Aurobindo Pharma Recent Development
Table 107. Aspen Corporation Information
Table 108. Aspen Description and Business Overview
Table 109. Aspen Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2016-2021)
Table 110. Aspen Product
Table 111. Aspen Recent Development
Table 112. Novartis Corporation Information
Table 113. Novartis Description and Business Overview
Table 114. Novartis Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2016-2021)
Table 115. Novartis Product
Table 116. Novartis Recent Development
Table 117. BASF Corporation Information
Table 118. BASF Description and Business Overview
Table 119. BASF Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2016-2021)
Table 120. BASF Product
Table 121. BASF Recent Development
Table 122. Pfizer Corporation Information
Table 123. Pfizer Description and Business Overview
Table 124. Pfizer Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2016-2021)
Table 125. Pfizer Product
Table 126. Pfizer Recent Development
Table 127. Huahai Pharmaceutical Corporation Information
Table 128. Huahai Pharmaceutical Description and Business Overview
Table 129. Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2016-2021)
Table 130. Huahai Pharmaceutical Product
Table 131. Huahai Pharmaceutical Recent Development
Table 132. Hisun Pharmaceutical Corporation Information
Table 133. Hisun Pharmaceutical Description and Business Overview
Table 134. Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2016-2021)
Table 135. Hisun Pharmaceutical Product
Table 136. Hisun Pharmaceutical Recent Development
Table 137. Sun Pharmaceutical Industries Corporation Information
Table 138. Sun Pharmaceutical Industries Description and Business Overview
Table 139. Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2016-2021)
Table 140. Sun Pharmaceutical Industries Product
Table 141. Sun Pharmaceutical Industries Recent Development
Table 142. Zhejiang Medicine Corporation Information
Table 143. Zhejiang Medicine Description and Business Overview
Table 144. Zhejiang Medicine Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2016-2021)
Table 145. Zhejiang Medicine Product
Table 146. Zhejiang Medicine Recent Development
Table 147. Dr. Reddy’s Laboratories Corporation Information
Table 148. Dr. Reddy’s Laboratories Description and Business Overview
Table 149. Dr. Reddy’s Laboratories Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2016-2021)
Table 150. Dr. Reddy’s Laboratories Product
Table 151. Dr. Reddy’s Laboratories Recent Development
Table 152. Zhejiang NHU Corporation Information
Table 153. Zhejiang NHU Description and Business Overview
Table 154. Zhejiang NHU Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2016-2021)
Table 155. Zhejiang NHU Product
Table 156. Zhejiang NHU Recent Development
Table 157. Bayer Corporation Information
Table 158. Bayer Description and Business Overview
Table 159. Bayer Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2016-2021)
Table 160. Bayer Product
Table 161. Bayer Recent Development
Table 162. NCPC Corporation Information
Table 163. NCPC Description and Business Overview
Table 164. NCPC Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2016-2021)
Table 165. NCPC Product
Table 166. NCPC Recent Development
Table 167. AbbVie Corporation Information
Table 168. AbbVie Description and Business Overview
Table 169. AbbVie Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2016-2021)
Table 170. AbbVie Product
Table 171. AbbVie Recent Development
Table 172. Shandong Xinhua Pharmaceutical Corporation Information
Table 173. Shandong Xinhua Pharmaceutical Description and Business Overview
Table 174. Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2016-2021)
Table 175. Shandong Xinhua Pharmaceutical Product
Table 176. Shandong Xinhua Pharmaceutical Recent Development
Table 177. Northeast Pharm Corporation Information
Table 178. Northeast Pharm Description and Business Overview
Table 179. Northeast Pharm Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2016-2021)
Table 180. Northeast Pharm Product
Table 181. Northeast Pharm Recent Development
Table 182. Harbin Pharmaceutical Corporation Information
Table 183. Harbin Pharmaceutical Description and Business Overview
Table 184. Harbin Pharmaceutical Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2016-2021)
Table 185. Harbin Pharmaceutical Product
Table 186. Harbin Pharmaceutical Recent Development
Table 187. LKPC Corporation Information
Table 188. LKPC Description and Business Overview
Table 189. LKPC Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2016-2021)
Table 190. LKPC Product
Table 191. LKPC Recent Development
Table 192. Active Pharmaceutical Ingredients (API) Market Trends
Table 193. Active Pharmaceutical Ingredients (API) Market Drivers
Table 194. Active Pharmaceutical Ingredients (API) Market Challenges
Table 195. Active Pharmaceutical Ingredients (API) Market Restraints
Table 196. Active Pharmaceutical Ingredients (API) Customers List
Table 197. Active Pharmaceutical Ingredients (API) Distributors List
Table 198. Research Programs/Design for This Report
Table 199. Key Data Information from Secondary Sources
Table 200. Key Data Information from Primary Sources
List of Figures
Figure 1. Active Pharmaceutical Ingredients (API) Product Picture
Figure 2. Global Active Pharmaceutical Ingredients (API) Sales Market Share by Type in 2020 & 2027
Figure 3. Synthetic APIs Product Picture
Figure 4. Biotech APIs Product Picture
Figure 5. Global Active Pharmaceutical Ingredients (API) Sales Market Share by Application in 2020 & 2027
Figure 6. CNS
Figure 7. Cardiovascular
Figure 8. Genitourinary/Hormonal Drugs
Figure 9. Respiratory
Figure 10. Rheumatology
Figure 11. Diabetes
Figure 12. Oncology
Figure 13. Others
Figure 14. Active Pharmaceutical Ingredients (API) Report Years Considered
Figure 15. Global Active Pharmaceutical Ingredients (API) Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Active Pharmaceutical Ingredients (API) Market Size 2016-2027 (US$ Million)
Figure 17. Global Active Pharmaceutical Ingredients (API) Sales 2016-2027 (Tons)
Figure 18. Global Active Pharmaceutical Ingredients (API) Market Size Market Share by Region: 2021 Versus 2027
Figure 19. Global Active Pharmaceutical Ingredients (API) Sales Market Share by Region (2016-2021)
Figure 20. Global Active Pharmaceutical Ingredients (API) Sales Market Share by Region in 2020
Figure 21. Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Region (2016-2021)
Figure 22. Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Region in 2020
Figure 23. Global Active Pharmaceutical Ingredients (API) Sales Share by Manufacturer in 2020
Figure 24. The Top 10 and 5 Players Market Share by Active Pharmaceutical Ingredients (API) Revenue in 2020
Figure 25. Active Pharmaceutical Ingredients (API) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 26. Global Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2016-2021)
Figure 27. Global Active Pharmaceutical Ingredients (API) Sales Market Share by Type in 2020
Figure 28. Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Type (2016-2021)
Figure 29. Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Type in 2020
Figure 30. Global Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2016-2021)
Figure 31. Global Active Pharmaceutical Ingredients (API) Sales Market Share by Application in 2020
Figure 32. Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Application (2016-2021)
Figure 33. Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Application in 2020
Figure 34. China Active Pharmaceutical Ingredients (API) Sales Growth Rate 2016-2027 (Tons)
Figure 35. China Active Pharmaceutical Ingredients (API) Revenue Growth Rate 2016-2027 (US$ Million)
Figure 36. China Active Pharmaceutical Ingredients (API) Market Share in Global Market 2016-2027
Figure 37. China 5 and 10 Largest Active Pharmaceutical Ingredients (API) Players Market Share by Revenue in Active Pharmaceutical Ingredients (API) in 2020
Figure 38. China Active Pharmaceutical Ingredients (API) Revenue Share by Type (2016-2021)
Figure 39. China Active Pharmaceutical Ingredients (API) Revenue Growth Rate by Type in 2016 & 2020
Figure 40. China Active Pharmaceutical Ingredients (API) Revenue Share by Application (2016-2021)
Figure 41. China Active Pharmaceutical Ingredients (API) Revenue Growth Rate by Application in 2016 & 2020
Figure 42. North America Active Pharmaceutical Ingredients (API) Sales Growth Rate 2016-2021 (Tons)
Figure 43. North America Active Pharmaceutical Ingredients (API) Revenue Growth Rate 2016-2021 (US$ Million)
Figure 44. North America Active Pharmaceutical Ingredients (API) Sales Market Share by Country in 2020
Figure 45. North America Active Pharmaceutical Ingredients (API) Revenue Market Share by Country in 2020
Figure 46. U.S. Active Pharmaceutical Ingredients (API) Sales Growth Rate (2016-2021) (Tons)
Figure 47. U.S. Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Canada Active Pharmaceutical Ingredients (API) Sales Growth Rate (2016-2021) (Tons)
Figure 49. Canada Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 50. Europe Active Pharmaceutical Ingredients (API) Sales Growth Rate 2016-2021 (Tons)
Figure 51. Europe Active Pharmaceutical Ingredients (API) Revenue Growth Rate 2016-2021 (US$ Million)
Figure 52. Europe Active Pharmaceutical Ingredients (API) Sales Market Share by Country in 2020
Figure 53. Europe Active Pharmaceutical Ingredients (API) Revenue Market Share by Country in 2020
Figure 54. Germany Active Pharmaceutical Ingredients (API) Sales Growth Rate (2016-2021) (Tons)
Figure 55. Germany Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 56. France Active Pharmaceutical Ingredients (API) Sales Growth Rate (2016-2021) (Tons)
Figure 57. France Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 58. U.K. Active Pharmaceutical Ingredients (API) Sales Growth Rate (2016-2021) (Tons)
Figure 59. U.K. Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 60. Italy Active Pharmaceutical Ingredients (API) Sales Growth Rate (2016-2021) (Tons)
Figure 61. Italy Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 62. Russia Active Pharmaceutical Ingredients (API) Sales Growth Rate (2016-2021) (Tons)
Figure 63. Russia Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 64. Asia Pacific Active Pharmaceutical Ingredients (API) Sales Growth Rate 2016-2021 (Tons)
Figure 65. Asia Pacific Active Pharmaceutical Ingredients (API) Revenue Growth Rate 2016-2021 (US$ Million)
Figure 66. Asia Pacific Active Pharmaceutical Ingredients (API) Sales Market Share by Region in 2020
Figure 67. Asia Pacific Active Pharmaceutical Ingredients (API) Revenue Market Share by Region in 2020
Figure 68. China Active Pharmaceutical Ingredients (API) Sales Growth Rate (2016-2021) (Tons)
Figure 69. China Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 70. Japan Active Pharmaceutical Ingredients (API) Sales Growth Rate (2016-2021) (Tons)
Figure 71. Japan Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 72. South Korea Active Pharmaceutical Ingredients (API) Sales Growth Rate (2016-2021) (Tons)
Figure 73. South Korea Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 74. India Active Pharmaceutical Ingredients (API) Sales Growth Rate (2016-2021) (Tons)
Figure 75. India Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 76. Australia Active Pharmaceutical Ingredients (API) Sales Growth Rate (2016-2021) (Tons)
Figure 77. Australia Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 78. Taiwan Active Pharmaceutical Ingredients (API) Sales Growth Rate (2016-2021) (Tons)
Figure 79. Taiwan Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 80. Indonesia Active Pharmaceutical Ingredients (API) Sales Growth Rate (2016-2021) (Tons)
Figure 81. Indonesia Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 82. Thailand Active Pharmaceutical Ingredients (API) Sales Growth Rate (2016-2021) (Tons)
Figure 83. Thailand Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 84. Malaysia Active Pharmaceutical Ingredients (API) Sales Growth Rate (2016-2021) (Tons)
Figure 85. Malaysia Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 86. Philippines Active Pharmaceutical Ingredients (API) Sales Growth Rate (2016-2021) (Tons)
Figure 87. Philippines Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 88. Vietnam Active Pharmaceutical Ingredients (API) Sales Growth Rate (2016-2021) (Tons)
Figure 89. Vietnam Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 90. Latin America Active Pharmaceutical Ingredients (API) Sales Growth Rate 2016-2021 (Tons)
Figure 91. Latin America Active Pharmaceutical Ingredients (API) Revenue Growth Rate 2016-2021 (US$ Million)
Figure 92. Latin America Active Pharmaceutical Ingredients (API) Sales Market Share by Country in 2020
Figure 93. Latin America Active Pharmaceutical Ingredients (API) Revenue Market Share by Country in 2020
Figure 94. Mexico Active Pharmaceutical Ingredients (API) Sales Growth Rate (2016-2021) (Tons)
Figure 95. Mexico Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 96. Brazil Active Pharmaceutical Ingredients (API) Sales Growth Rate (2016-2021) (Tons)
Figure 97. Brazil Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 98. Argentina Active Pharmaceutical Ingredients (API) Sales Growth Rate (2016-2021) (Tons)
Figure 99. Argentina Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 100. Middle East and Africa Active Pharmaceutical Ingredients (API) Sales Growth Rate 2016-2021 (Tons)
Figure 101. Middle East and Africa Active Pharmaceutical Ingredients (API) Revenue Growth Rate 2016-2021 (US$ Million)
Figure 102. Middle East and Africa Active Pharmaceutical Ingredients (API) Sales Market Share by Country in 2020
Figure 103. Middle East and Africa Active Pharmaceutical Ingredients (API) Revenue Market Share by Country in 2020
Figure 104. Turkey Active Pharmaceutical Ingredients (API) Sales Growth Rate (2016-2021) (Tons)
Figure 105. Turkey Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 106. Saudi Arabia Active Pharmaceutical Ingredients (API) Sales Growth Rate (2016-2021) (Tons)
Figure 107. Saudi Arabia Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 108. U.A.E Active Pharmaceutical Ingredients (API) Sales Growth Rate (2016-2021) (Tons)
Figure 109. U.A.E Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 110. Active Pharmaceutical Ingredients (API) Value Chain
Figure 111. Channels of Distribution
Figure 112. Distributors Profiles
Figure 113. Bottom-up and Top-down Approaches for This Report
Figure 114. Data Triangulation
Figure 115. Key Executives Interviewed


*** 掲載企業 ***

Teva、Mylan、DSM、Aurobindo Pharma、Aspen、Novartis、BASF、Pfizer、Huahai Pharmaceutical、Hisun Pharmaceutical、Sun Pharmaceutical Industries、Zhejiang Medicine、Dr. Reddy’s Laboratories、Zhejiang NHU、Bayer、NCPC、AbbVie、Shandong Xinhua Pharmaceutical、Northeast Pharm、Harbin Pharmaceutical、LKPC

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(QY21CN0335 )"有効成分(API)のグローバル及び中国市場 2027年" (英文:Global and China Active Pharmaceutical Ingredients (API) Market Insights, Forecast to 2027)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。